Sino Biopharmaceutica Profit Margin vs. Gross Profit
| SBMFF Stock | USD 0.41 0.00 0.00% |
For Sino Biopharmaceutica profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sino Biopharmaceutica to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sino Biopharmaceutical Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sino Biopharmaceutica's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sino Biopharmaceutical Limited over time as well as its relative position and ranking within its peers.
Sino |
Sino Biopharmaceutical Gross Profit vs. Profit Margin Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sino Biopharmaceutica's current stock value. Our valuation model uses many indicators to compare Sino Biopharmaceutica value to that of its competitors to determine the firm's financial worth. Sino Biopharmaceutical Limited is currently regarded as top stock in profit margin category among its peers. It also is currently regarded as top stock in gross profit category among its peers fabricating about 74,085,550,585 of Gross Profit per Profit Margin. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sino Biopharmaceutica's earnings, one of the primary drivers of an investment's value.Sino Gross Profit vs. Profit Margin
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Sino Biopharmaceutica |
| = | 0.29 % |
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Sino Biopharmaceutica |
| = | 21.53 B |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Sino Gross Profit Comparison
Sino Biopharmaceutica is currently under evaluation in gross profit category among its peers.
Sino Biopharmaceutica Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sino Biopharmaceutica, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sino Biopharmaceutica will eventually generate negative long term returns. The profitability progress is the general direction of Sino Biopharmaceutica's change in net profit over the period of time. It can combine multiple indicators of Sino Biopharmaceutica, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutic is traded on OTC Exchange in the United States.
Sino Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sino Biopharmaceutica. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sino Biopharmaceutica position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sino Biopharmaceutica's important profitability drivers and their relationship over time.
Use Sino Biopharmaceutica in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sino Biopharmaceutica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will appreciate offsetting losses from the drop in the long position's value.Sino Biopharmaceutica Pair Trading
Sino Biopharmaceutical Limited Pair Trading Analysis
The ability to find closely correlated positions to Sino Biopharmaceutica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sino Biopharmaceutica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sino Biopharmaceutica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sino Biopharmaceutical Limited to buy it.
The correlation of Sino Biopharmaceutica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sino Biopharmaceutica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sino Biopharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sino Biopharmaceutica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sino Biopharmaceutica position
In addition to having Sino Biopharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Sino Pink Sheet
To fully project Sino Biopharmaceutica's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sino Biopharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sino Biopharmaceutica's income statement, its balance sheet, and the statement of cash flows.